Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis (Q38986144)

8 September 2017

1 reference

title

Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis (English)

1 reference

8 September 2017

Li Zhou

1

1 reference

8 September 2017

Ji Wen

2

1 reference

8 September 2017

Zhao Huang

3

1 reference

8 September 2017

Edouard C Nice

4

1 reference

8 September 2017

Canhua Huang

5

1 reference

8 September 2017

Haiyuan Zhang

6

1 reference

8 September 2017

Qifu Li

7

1 reference

8 September 2017

20 October 2016

1 reference

Proteomics - Clinical Applications

8 September 2017

1 reference

8 September 2017

11

1 reference

8 September 2017

3-4

1 reference

Global cancer statistics, 2012

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Cellular and molecular mechanisms of hepatocellular carcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatocellular carcinoma: clinical frontiers and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidative and antioxidative mechanisms in oral cancer and precancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Modulation of oxidative stress as an anticancer strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Regulation of cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Physiological roles of mitochondrial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox-based regulation of signal transduction: principles, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Mitochondrial reactive oxygen species drive proinflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidative DNA damage and disease: induction, repair and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox proteomics: chemical principles, methodological approaches and biological/biomedical promises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Quantitative reactivity profiling predicts functional cysteines in proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox proteomics and drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox proteomics: from protein modifications to cellular dysfunction and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Functional and genetic deconstruction of the cellular origin in liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

NF-κB and STAT3 - key players in liver inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus X gene is implicated in liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus-cell interactions and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Unravelling hepatitis C virus replication from genome to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Adaptive immune responses in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

CARD games between virus and host get a new player

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus-induced hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Transcriptional repression of p53 promoter by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Physical and functional interaction between HCV core protein and the different p73 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Reactive oxygen species in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Cell signaling in oxidative stress-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Bioenergetics and the formation of mitochondrial reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Autophagy is activated for cell survival after endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Reactive oxygen species: a breath of life or death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidative stress and epigenetic instability in human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Suppression of a pro-apoptotic K+ channel as a mechanism for hepatitis C virus persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

FOXOs: signalling integrators for homeostasis maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidative stress and cancer: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Identification of the oxidative stress proteome in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Gel-based methods in redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Gel-free proteomic methodologies to study reversible cysteine oxidation and irreversible protein carbonyl formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The development of the DIGE system: 2D fluorescence difference gel analysis technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Basal and stimulated protein S-nitrosylation in multiple cell types and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Site-Specific Proteomic Mapping Identifies Selectively Modified Regulatory Cysteine Residues in Functionally Distinct Protein Networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Quantifying changes in the thiol redox proteome upon oxidative stress in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The redoxome: Proteomic analysis of cellular redox networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Monitoring in vivo reversible cysteine oxidation in proteins using ICAT and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

High-throughput screening of cellular redox sensors using modern redox proteomics approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Species identification and vitamin A level in lutjanid fish implicated in vitamin A poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Quantification of mitochondrial S-nitrosylation by CysTMT⁶ switch assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

cysTMTRAQ-An integrative method for unbiased thiol-based redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Mass spectrometry-based quantitative proteomics for dissecting multiplexed redox cysteine modifications in nitric oxide-protected cardiomyocyte under hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Differential oxidation of protein-tyrosine phosphatases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox redux: revisiting PTPs and the control of cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Applying mass spectrometry-based proteomics to genetics, genomics and network biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Mass spectrometry-based proteomics in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox proteomics: Methods for the identification and enrichment of redox-modified proteins and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

A tandem orthogonal proteolysis strategy for high-content chemical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)--a general method for mapping sites of probe modification in proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Protein targets of reactive electrophiles in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Thiol-based redox proteomics in cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

An overview of mechanisms of redox signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Protein sulfenic acids in redox signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Redox sensing by proteins: oxidative modifications on cysteines and the consequent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Global analysis of myocardial peptides containing cysteines with irreversible sulfinic and sulfonic acid post-translational modifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Sulfur and selenium: the role of oxidation state in protein structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Conserved regulatory elements in AMPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Chemical approaches to discovery and study of sources and targets of hydrogen peroxide redox signaling through NADPH oxidase proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

EFFECT OF ETHANOL AND ACETALDEHYDE ON LIVER AND BRAIN MONOAMINE OXIDASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

An examination of liver offers to candidates on the liver transplant wait-list

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The role of hepatic resection in the treatment of hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

No evident dose-response relationship between cellular ROS level and its cytotoxicity--a paradoxical issue in ROS-based cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

HIF-dependent antitumorigenic effect of antioxidants in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Antioxidants accelerate lung cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Revisiting oxaliplatin-based regimens for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

Difference gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600089

21 January 2018

Identifiers

DOI

10.1002/PRCA.201600089

1 reference

8 September 2017

1 reference